Efficacy and safety of fast-acting insulin aspart in adults with type 2 diabetes with different insulin requirements

被引：0
|
作者：
Sesti, G. [1 ]
Lane, W. [2 ]
Ekelund, M. [3 ]
Thorisdottir, O. [3 ]
Jodar, E. [4 ]
Oviedo, A. [5 ,6 ]
Rathor, N. [7 ]
Senior, P. [8 ]
Franek, E. [9 ,10 ]
机构：
[1] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy
[2] Mt Diabet & Endocrine Ctr, Asheville, NC USA
[3] Novo Nordisk AS, Soborg, Denmark
[4] Univ Europea, Univ Hosp Quironsalud Madrid, Madrid, Spain
[5] Santojanni Hosp, Buenos Aires, DF, Argentina
[6] Cenudiab, Buenos Aires, DF, Argentina
[7] Novo Nordisk Serv Ctr India Private Ltd, Bangalore, Karnataka, India
[8] Univ Alberta, Div Endocrinol & Metab, Edmonton, AB, Canada
[9] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland
[10] CSK MSWiA, Dept Endocrinol & Diabetol, Warsaw, Poland
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
684
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Fast-Acting Insulin Aspart in Adults with T2D with Different Insulin Requirements
    Lane, Wendy
    Ekelund, Magnus
    Thorisdottir, Olof
    Jodar, Esteban
    Oviedo, Alejandra
    Rathor, Naveen
    Senior, Peter
    Sesti, Giorgio
    Franek, Edward
    [J]. DIABETES, 2020, 69
  • [2] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both with insulin degludec with or without metformin, in adults with type 2 diabetes
    Lane, W.
    Bozkurt, K.
    Favaro, E.
    Jang, H. C.
    Kjaersgaard, M. I. S.
    Oviedo, A.
    Rose, L.
    Senior, P.
    Sesti, G.
    Soto Gonzalez, A.
    Franek, E.
    [J]. DIABETOLOGIA, 2019, 62 : S10 - S11
  • [3] Efficacy and safety of fast-acting insulin aspart versus insulin aspart both in combination with insulin degludec with or without metformin in adults with diabetes
    Du, J.
    Wang, G. X.
    Wang, G.
    Liu, M.
    Thamattoor, U. K.
    Luan, Z. J.
    Alibegovic, A. C.
    Mu, Y. M.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S377 - S377
  • [4] Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan
    Kawamura, Tomoyuki
    Kikuchi, Toru
    Horio, Hiroshi
    Rathor, Naveen
    Ekelund, Magnus
    [J]. ENDOCRINE JOURNAL, 2021, 68 (04) : 409 - 420
  • [5] A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)
    Lane, Wendy S.
    Favaro, Elena
    Rathor, Naveen
    Jang, Hak C.
    Kjaersgaard, Maiken I. S.
    Oviedo, Alejandra
    Rose, Ludger
    Senior, Peter
    Sesti, Giorgio
    Soto Gonzalez, Alfonso
    Franek, Edward
    [J]. DIABETES CARE, 2020, 43 (08) : 1710 - 1716
  • [6] FAST-ACTING INSULIN ASPART AT HIGH DOSES IN INDIVIDUALS WITH TYPE 2 DIABETES
    Bowering, K.
    Harvey, J.
    Kolaczynski, J.
    Snyder, J.
    Bode, B.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A133 - A133
  • [7] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart in combination with insulin degludec in Japanese adults with type 1 diabetes: a subgroup analysis of the randomized onset 8 trial
    Komatsu, Mitsuhisa
    Ekelund, Magnus
    Horio, Hiroshi
    Kadowaki, Takashi
    [J]. ENDOCRINE JOURNAL, 2021, 68 (04) : 429 - 440
  • [8] Cost impact analysis of mealtime fast-acting insulin aspart compared with insulin aspart in adults with Type 1 diabetes in the UK
    Pollock, R. F.
    Parekh, W.
    Watcham, S.
    Hallen, N.
    [J]. DIABETIC MEDICINE, 2019, 36 : 166 - 166
  • [9] Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial
    Bode, Bruce W.
    Iotova, Violeta
    Kovarenko, Margarita
    Laffel, Lori M.
    Rao, Paturi V.
    Deenadayalan, Srikanth
    Ekelund, Magnus
    Larsen, Steffen Falgreen
    Danne, Thomas
    [J]. DIABETES CARE, 2019, 42 (07) : 1255 - 1262
  • [10] Fast-Acting Insulin aspart (faster aspart) - Clinical Data on Application in Type 1 and 2 Diabetes
    Jaeckel, E.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (06): : 313 - 319
12345